Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema

NCT00682539 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: Bevacizumab (Avastin)
DRUG: Triamcinolone
DRUG: Sham
PROCEDURE: Lucentis

Sponsor

Medical University of Vienna